Rewind Therapeutics
- Biotech or pharma, therapeutic R&D
Rewind Therapeutics is a pre-clinical stage biotech, developing small molecule therapies to re-initiate the process of remyelination in patients suffering from major debilitating demyelinating diseases such as multiple sclerosis, optic neuritis or nerve injuries.



